Addex Therapeutics Ltd is a biopharmaceutical company. The company operates through single segment which includes developing drugs to improve human health. It is focused on the development of novel, orally available, small molecule allosteric modulators for neurological disorders. In addition, it is also engaged in the development of the dipraglurant and ADX71441 program. The company's geographical area of operations includes Switzerland and Europe.
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-17 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.090 | ||||||
| REV | 2.093M |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| ADXN | Addex Therapeutics | -1.46% | 57.5M |
Addex Therapeutics Company Questions & Answers
Q
How do I buy Addex Therapeutics (ADXN) stock?
A
You can purchase shares of Addex Therapeutics (NASDAQ: ADXN) through any online brokerage.
Q
Who are Addex Therapeutics's (ADXN) main competitors?
A
There are no as such competitors for Addex Therapeutics.
Q
What is the target price for Addex Therapeutics?
A
There is no analysis for Addex Therapeutics
Q
How much is Addex Therapeutics (ADXN) stock ?
A
The stock price for Addex Therapeutics (NASDAQ: ADXN) is $10.13 last updated Tue Apr 20 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Addex Therapeutics (ADXN) dividend?
A
There are no upcoming dividends for Addex Therapeutics.
Q
When is Addex Therapeutics (NASDAQ:ADXN) reporting earnings?
A
Addex Therapeutics’s Q1 earnings are confirmed after-market from now on May 17, 2021.
Q
When is the upcoming split for ADXN?
A
There is no upcoming split for Addex Therapeutics.